Change Is the Only Constant
September 6, 2022
Kimberly Barnes, Executive Vice President of Phacilitate, gives her view on cell and gene trends, diversity, and how industry events are changing
9 min read
August 2022
If women and girls make up half of our global population, then why is there a dearth of medicine to cater to their unique needs? We examine this issue in our cover feature, and look at initiatives and projects that help to address this area of unmet patient need. We then invite you to take a look at the past and discover how two prominent figures helped address a global infectious disease crisis with accessibility and equity in mind. In this issue, you can also find commentary on pharma’s relationship with sustainable practices, a recap of ISCT’s latest cell and gene conference, and an interview with formulation science veteran, Chris Moreton.
“Could You Patent the Sun?” – Jonas Salk, Albert Sabin, and the Polio Vaccine
September 5, 2022
How two rival projects relate to a modern disease landscape threatened by climate change and low vaccination rates
18 min read
A History of Missed Opportunity
September 2, 2022
Decades' worth of exclusion has resulted in a knowledge gap in the women's health sphere. But as pharma companies reevaluate their approach to medicine making in this area, they will have to acknowledge the past that has contributed to the current R&D outlook
13 min read
The Formulation Fixer
August 8, 2022
Sitting Down With… Chris Moreton, Partner, FinnBrit Consulting
7 min read
The Candy Coder
August 2, 2022
How can data be stored in candy? And how could it be used to fight counterfeit medicine?
9 min read
Pharma’s Green Progress and Pitfalls
June 3, 2022
Where are pharma companies falling behind when it comes to the environment?
4 min read
Securing Supply: Best Practices for Critical Raw Materials
May 24, 2022
COVID-19 has taught us that unexpected events can cause significant supply chain disruption – and there’s no better time to consider secondary and tertiary sources.
6 min read
Protect the Virus!
May 11, 2022
Viral vectors can enable innovative medical treatments, but only if we address the unstable elephant in the room with a comprehensive formulation development plan
1 min read
